POSC66 Cost-Effectiveness of Avelumab as First-Line Maintenance Treatment for Locally Advanced or Metastatic Urothelial Carcinoma in Finland

Category Primary study
JournalValue in Health
Year 2022
This article has no abstract
Epistemonikos ID: b331b284e9dc9d12264fe5c546421fab8399be40
First added on: Feb 13, 2025